Recently we showed that the glycine-rich loop in the N-terminal portion of protein kinases and the clientbinding site of Cdc37 are both necessary for interaction between Cdc37 and protein kinases. We demonstrate here that the N-terminal portion of Cdc37, distinct from its client-binding site, interacts with the C-terminal portion of Raf-1. This interaction might expose the client-binding site of Cdc37. In addition, we provide evidence indicating that Cdc37 is monomeric in its physiological state, and that it becomes a dimer only when it is complexed with both Hsp90 and protein kinases.
Many proteins are critically dependent on molecular chaperones for their biogenesis. 1, 2) Although one molecular chaperone, the 90-kDa heat shock protein (Hsp90), is considered to participate in the later stages of biosynthesis of newly translated proteins, the underlying molecular mechanism is still obscured; by contrast, Hsp70 and chaperonin function in an early phase of the folding of nascent proteins. [3] [4] [5] [6] [7] Among proteins requiring the assistance of Hsp90 (viz., Hsp90 client proteins), protein kinases represent the largest group. [3] [4] [5] [6] [7] In general, Hsp90 is unable to accomplish its chaperoning function on its own and, instead, needs multiple types of co-chaperone protein. Hsp90 executes its role as a molecular chaperone in a manner dependent on its own ATPase activity. This ATPase-dependent chaperone cycle is, however, intricately regulated by the cochaperones. [3] [4] [5] [6] [7] Cdc37/p50 is one such Hsp90 co-chaperone that is mainly regarded as a protein kinase-specific co-chaperone for Hsp90. 8, 9) Cdc37 interacts both physically and genetically with a variety of protein kinases, including pp60
v-src , 10) Raf-1, 11) Cdk2, 12) and Cdk4. 13) By contrast, the biogenesis of some protein kinases, such as the catalytic subunit of cAMP-dependent protein kinase (PKA), 14) has been reported to be independent of Cdc37 and Hsp90, and these protein kinases have been regarded as non-client protein kinases. We have shown recently, however, that PKA can interact with Cdc37, but only when the activation segment in its C-lobe is unphosphorylated. Hence, the accepted mechanism of discrimination between client and non-client kinases needs re-evaluation. 15) Cdc37 associates with the N-terminal portion of protein kinase. [16] [17] [18] More specifically, the 20-residue (residues 181-200) client-binding site of Cdc37 and the glycine-rich loop in the N-terminal portion of the protein kinase are both necessary for physical interaction between the two proteins. 15, 16) Concomitant with its binding to client protein kinases, Cdc37 also binds to Hsp90 directly. [19] [20] [21] The middle segment of Cdc37 has been shown to interact with the N-terminal ATP-binding domain of Hsp90 in the latest crystallographic study. 22) In the crystal structure, Cdc37 binds to the open face of the N-terminal domain of Hsp90 and interferes with conformational changes in Hsp90, which probably leads to inhibition of the ATPase activity of Hsp90. Taken altogether, these findings suggest that Cdc37 has a role in client recruitment to Hsp90, but the underlying molecular mechanism remains to be elucidated.
Cdc37 was divided into the N-and C-terminal portions between amino acid residues 163 and 164 20, 23) to form Cdc37N (residues 1-163) and Cdc37C (residues 164-378) respectively: FLAG-tagged Cdc37N (residues 1-163) and Cdc37C (residues 164-378) variants were y To whom correspondence should be addressed. Michiko MINAMI, Tel: +81-42-329-7435; Fax: +81-42-329-7435; E-mail: minami@u-gakugei.
ac.jp; Yasufumi MINAMI, Tel: +81-48-268-7274; Fax: +81-48-268-7274; E-mail: yminami@biochem.s.u-tokyo.ac.jp Abbreviations: GST, glutathione S-transferase; IP, immunoprecipitation; PKA, the catalytic subunit of cAMP-dependent protein kinase; WB, immunoblotting produced according to a previously described procedure, 16) and the binding ability of these two variants to the Raf-1 kinase domain was analyzed. Consistent with our previous results, 15, 16) Cdc37C, which embraces the client-binding site (residues 181-200), co-immunoprecipitated the kinase domain to an extent similar to that of full-length Cdc37 (Fig. 1A , immunoprecipitation (IP): -FLAG, top). This observation was corroborated by an inverse IP experiment (Fig. 1A , IP: -Myc, bottom), and was recapitulated for the whole Raf-1 molecule when it was used in place of the kinase domain in binding assays (Fig. 1B) . By contrast, the binding activity of Cdc37N towards the full-length protein and the kinase domain of Raf-1 was much less than that of full-length Cdc37 or Cdc37C ( Fig. 1A and B). It should be noted, however, that this low activity was reproducibly detected and might be somewhat significant (Fig. 1A , IP: -FLAG, top). Our data appear to contradict those of others, 20, 23) but the reason for this discrepancy remains unknown. Nevertheless, despite the fact that the 20-residue clientbinding site of Cdc37 represents the primary binding motif for protein kinases, as has been reported, 16) these observations suggest that another binding site for protein kinases might exist in the N-terminal portion of Cdc37.
To address this issue, 13 residues in the N terminus of Cdc37 (residues 26-38) were deleted internally, because an in-frame deletion of the corresponding amino acids in fly protein has previously been reported to result in a Cdc37 mutant. 24) This internal deletion in fly Cdc37 was reported to impair signaling by the sevenless receptor tyrosine kinase. Cdc37 cDNA 16) was subcloned into a pCR-Blunt plasmid (Invitrogen, Carlsbad, CA), and then an MluI site was introduced at nucleotide position 76 of Cdc37 using a QuickChange Site-directed Mutagenesis kit (Stratagene, La Jolla, CA), yielding pCR-BluntCdc37/MluI. The region of Cdc37 between residues 38 and 378 was amplified by PCR with a 5 0 -end primer containing an MluI site and an M13 reverse primer (as a 3 0 -end primer), followed by cutting with MluI. The resulting MluI-fragment was introduced at the MluI site of the pCR-Blunt-Cdc37/MluI to produce pCR-BluntCdc37Á13. The pCR-Blunt-Cdc37Á13 obtained was cut with both BamHI and EcoRI, and then ligated to the pcDNA3FLAG1 plasmid cut with both BamHI and EcoRI to yield a plasmid to express FLAG-Cdc37Á13. As shown in Fig. 2A , the binding activity of Cdc37 toward the Raf-1 kinase domain was completely lost by this internal deletion mutation. In addition, we found that truncation of the N-terminal 40 residues, which are the most conserved amino acids among different A, The Myc-tagged kinase domain of Raf-1 (Myc-Knd) and FLAG-tagged full-length Cdc37 (FL), Cdc37N (N), or Cdc37C (C) were coexpressed in COS7 cells. COS7 cells were transfected with Lipofectamine Plus (Invitrogen, Carlsbad, CA), according to the manufacturer's protocol, and cultured at 37 C in Dulbecco's modified Eagle's medium containing 10% (v/v) fetal bovine serum. Cell extracts (Whole) were subjected to immunoprecipitation (IP) with anti-FLAG (IP: -FLAG) or anti-Myc (IP: -Myc) antibody, followed by immunoblotting (WB) with the indicated antibodies. Cells lysis, IP, and WB were performed as described previously. 15, 16) An asterisk indicates nonspecific bands. B, Myctagged whole Raf-1 protein was used in place of Myc-Knd, and the immunoprepitates with anti-Myc antibody were analyzed by immunostaining, as described in A. species, 13, 23) abolished the binding activity of Cdc37 (data not shown). These observations support our assumption described above and are also in line with previous studies, 23, 25) which have shown that the Nterminal portion of Cdc37 plays a critical role in its client binding.
In our previous study, in which kinase domain of Raf-1 was divided into N-(subdomains I-IV) and C-terminal (subdomains V-XI) portions, 26) the N-terminal but not the C-terminal portion was found to bind to the Cdc37 fragment Cdc37 (181-378), which represents the minimum region in which the kinase-binding activity is preserved. 16 ) Intriguingly, although full-length Cdc37 does not associate with this N-terminal portion of Raf-1 on its own, the presence of the C-terminal portion of Raf-1 enables full-length Cdc37 to bind the N-terminal portion. 15) Taking these findings together, we concluded that Cdc37N might associate with the C-terminal portion of Raf-1 via a potential second binding site, and that this association can eventually trigger a dynamic architectural alteration in the whole Cdc37 molecule, thereby enabling the otherwise inaccessible client-binding site to be accessed by the N-terminal portion of Raf-1, which contains the glycine-rich loop responsible for its stable binding to Cdc37.
As shown in Fig. 2B (IP: -FLAG), Cdc37N showed a rather low activity for binding the Raf-1 kinase domain, which recapitulated the result shown in Fig. 1A . In this experiment, the kinase domain was fused to Myc-glutathione S-transferase (GST) and not Myc-tagged (cf. Fig. 1A and 2B ). In addition, as expected, Cdc37N efficiently co-immunoprecipitated the C-terminal but not the N-terminal portion of Raf-1. Of note, the binding affinity of Cdc37N for the Cterminal portion of Raf-1 was significantly stronger than that for the whole kinase domain of Raf-1 (Fig. 2B) . Furthermore, Cdc37NÁ13, in which the 13 abovementioned residues were internally excised from Cdc37N, completely lost its activity for binding both the whole kinase domain and the C-terminal portion of Raf-1 (Fig. 2B) . The pCR-Blunt Cdc37Á13 plasmid was used as the template for PCR to construct a plasmid for expression of FLAG-Cdc37NÁ13, as described above. Collectively, these results substantiate our conclusion that these 13 residues in the N terminus of Cdc37 might be required for Cdc37N to interact with the C-terminal portion of Raf-1, which is probably a prerequisite for the stable binding of Raf-1 by Cdc37 via its client-binding site. Hence, deletion of these 13 residues would abolish this priming association between the N-terminal portion of Cdc37 and the C-terminal portion of Raf-1, and the corresponding mutation might be a cause of the impairment of sevenless receptor kinase signaling observed in the fly Cdc37 mutant.
A previous study showed that client proteins enhance the interaction between Hsp90 and Cdc37. 21) In addition, it has been suggested that Cdc37 might not interact with Hsp90 as a pre-formed dimer, but rather that the binding A, The Myc-tagged kinase domain of Raf-1 (Myc-Knd) and FLAG-tagged wild-type (wt) or mutant Cdc37 (Á13) were coexpressed in COS7 cells, and cell extracts (Whole) were subjected to immunoprecipitation (IP) with anti-FLAG (IP: -FLAG) or anti-Myc (IP: -Myc) antibody, followed by immunoblotting (WB) with the indicated antibodies. B, FLAG-tagged Cdc37N (N) or Cdc37NÁ13 (NÁ13) and Myc-GST alone (Empty) or Myc-GST fused to the kinase domain of Raf-1 (Knd), the N-terminal (I-IV), or the C-terminal (V-XI) portion of Raf-1 were coexpressed in COS7 cells, and cell lysates (Whole) were immunoprecipitated with anti-FLAG antibody (IP: -FLAG), and subjected to WB with the indicated antibodies.
of Cdc37 to Hsp90 may promote dimerization of Cdc37. 27) To address this possibility, FLAG-tagged Cdc37 (hereafter termed FLAG-Cdc37) was expressed in COS7 cells and examined for dimer formation with endogenously expressed Cdc37. FLAG-Cdc37 co-immunoprecipitated Hsp90 endogenously produced in COS7 cells, but no endogenous Cdc37 was present in the precipitates (Fig. 3A, IP: -FLAG). It should be noted, however, that the amount of endogenous Cdc37 was two-to threefold smaller than that of FLAG-Cdc37 (Fig. 3A, Whole) . When the kinase domain of Raf-1 was coexpressed in the cells, endogenous Cdc37 protein (Fig. 3B , immunoblotting (WB): -Cdc37), as well as the kinase domain of Raf-1 (Fig. 3B , WB: -Myc) and Hsp90 (data not shown), was co-immunoprecipitated with FLAG-Cdc37 (Fig. 3B ). Taking these observations together, it is plausible that although Cdc37 is usually (i.e., in the absence of protein kinases) monomeric and can interact with Hsp90 as a monomer, it does not form a stable dimer unless client kinases are present. In other words, Cdc37 cannot form a dimer until it is complexed with both Hsp90 and client kinases. Thus the mechanism of Cdc37 dimerization might consist of multiple steps that are implemented by an intricate collaboration among Cdc37, Hsp90, and protein kinases. As such, the integration of these multifaceted and simultaneously occurring interactions between each two of these three molecules must be examined in future investigations.
In summary, the present study provides evidence indicating that the binding activity of Cdc37 toward client protein kinases is dynamically regulated both intramolecularly and intermolecularly, as has been predicted previously. 16, 23) The molecular mechanism, however, remains to be resolved. A, COS7 cells containing a plasmid expressing FLAG-Cdc37 (+) or the corresponding vacant plasmid (À) were lysed (Whole) and subjected to immunoprecipitation (IP) with anti-FLAG antibody (IP: -FLAG), followed by immunoblotting (WB) with the indicated antibodies. B, Cells expressing FLAG-Cdc37 alone (À) or coexpressing FLAG-Cdc37 and the Myc-tagged kinase domain of Raf-1 (Myc-Knd) (+) were lysed (Whole) and subjected to IP with anti-FLAG antibody (IP: -FLAG), followed by WB with the indicated antibodies. endo Cdc37, Cdc37 endogenously expressed in the cell.
